Announcements Trials
Browse Landscape

Status

Recruiting 89Unknown 69Not yet recruiting 43Completed 29Active not recruiting 22Terminated 3Withdrawn 1Suspended 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

GastroEsophageal Cancer 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Immune Checkpoint Inhibitors × Clear all
NCT06283238 2026-01-29

Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

Duke University

Withdrawn
Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡